Your browser doesn't support javascript.
loading
Brusatol improves the efficacy of an anti-mouse-PD-1 antibody via inhibiting programmed cell death 1 ligand 1 expression in a murine head and neck squamous cell carcinoma model.
Wu, Yanlin; Zhang, Guilian; Yin, Panpan; Wen, Jinlin; Su, Ying; Zhang, Xinyan.
Afiliación
  • Wu Y; Beijing Institute of Dental Research, Beijing Stomatological Hospital and School of Stomatology, Capital Medical University, No.4 Tiantanxili, Dongcheng District, Beijing 100050, China.
  • Zhang G; Beijing Institute of Dental Research, Beijing Stomatological Hospital and School of Stomatology, Capital Medical University, No.4 Tiantanxili, Dongcheng District, Beijing 100050, China; Department of Stomatology, Beijing Children's Hospital, Capital Medical University, National Center for Children's
  • Yin P; Beijing Institute of Dental Research, Beijing Stomatological Hospital and School of Stomatology, Capital Medical University, No.4 Tiantanxili, Dongcheng District, Beijing 100050, China.
  • Wen J; Beijing Institute of Dental Research, Beijing Stomatological Hospital and School of Stomatology, Capital Medical University, No.4 Tiantanxili, Dongcheng District, Beijing 100050, China.
  • Su Y; Beijing Institute of Dental Research, Beijing Stomatological Hospital and School of Stomatology, Capital Medical University, No.4 Tiantanxili, Dongcheng District, Beijing 100050, China.
  • Zhang X; Beijing Institute of Dental Research, Beijing Stomatological Hospital and School of Stomatology, Capital Medical University, No.4 Tiantanxili, Dongcheng District, Beijing 100050, China. Electronic address: xinyanzhangzh@126.com.
Arch Oral Biol ; 166: 106043, 2024 Oct.
Article en En | MEDLINE | ID: mdl-38968906
ABSTRACT

OBJECTIVE:

Combing PD-1/PD-L1 immune checkpoint inhibitors with natural products has exhibited better efficacy than monotherapy. Hence, the purpose of this research was to examine the anti-cancer effects of brusatol, a natural quassinoid-terpenoid derived from Brucea javanica, when used in conjunction with an anti-mouse-PD-1 antibody in a murine head and neck squamous cell carcinoma (HNSCC) model and elucidate underlying mechanisms.

DESIGN:

A murine HNSCC model and an SCC-15 cell xenograft nude mouse model were established to investigate the anti-cancer effects of brusatol and anti-PD-1 antibody. Mechanistic studies were performed using immunohistochemistry. Cell proliferation, migration, colony formation, and invasion were evaluated by MTT, migration, colony formation, and transwell invasion assays. PD-L1 levels in oral squamous cell carcinoma (OSCC) cells were assessed through qRT-PCR, flow cytometry, and western blotting assays. The impact of brusatol on Jurkat T cell function was assessed by an OSCC/Jurkat co-culture assay.

RESULTS:

Brusatol improved tumor suppression by anti-PD-1 antibody in HNSCC mouse models. Mechanistic studies revealed brusatol inhibited tumor cell growth and angiogenesis, induced apoptosis, increased T lymphocyte infiltration, and reduced PD-L1 expression in tumors. Furthermore, in vitro assays confirmed brusatol inhibited PD-L1 expression in OSCC cells and suppressed cell migration, colony formation, and invasion. Co-culture assays indicated that brusatol's PD-L1 inhibition enhanced Jurkat T cell-mediated OSCC cell death and reversed the inhibitory effect induced by OSCC cells.

CONCLUSIONS:

Brusatol improves anti-PD-1 antibody efficacy by targeting PD-L1, suggesting its potential as an adjuvant in anti-PD-1 immunotherapy.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cuassinas / Proliferación Celular / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Carcinoma de Células Escamosas de Cabeza y Cuello / Ratones Desnudos Límite: Animals / Humans Idioma: En Revista: Arch Oral Biol Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cuassinas / Proliferación Celular / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Carcinoma de Células Escamosas de Cabeza y Cuello / Ratones Desnudos Límite: Animals / Humans Idioma: En Revista: Arch Oral Biol Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido